291 related articles for article (PubMed ID: 20102402)
21. nm23 protein expression in colorectal carcinoma metastasis in regional lymph nodes and the liver.
Sarris M; Lee CS
Eur J Surg Oncol; 2001 Mar; 27(2):170-4. PubMed ID: 11289754
[TBL] [Abstract][Full Text] [Related]
22. The deleted in colon cancer (DCC) gene is consistently expressed in colorectal cancers and metastases.
Gotley DC; Reeder JA; Fawcett J; Walsh MD; Bates P; Simmons DL; Antalis TM
Oncogene; 1996 Aug; 13(4):787-95. PubMed ID: 8761300
[TBL] [Abstract][Full Text] [Related]
23. Podoplanin expression identified in stromal fibroblasts as a favorable prognostic marker in patients with colorectal carcinoma.
Yamanashi T; Nakanishi Y; Fujii G; Akishima-Fukasawa Y; Moriya Y; Kanai Y; Watanabe M; Hirohashi S
Oncology; 2009; 77(1):53-62. PubMed ID: 19556810
[TBL] [Abstract][Full Text] [Related]
24. Bromodeoxyuridine uptake and proliferating cell nuclear antigen expression throughout the colorectal tumor sequence.
Risio M; Candelaresi G; Rossini FP
Cancer Epidemiol Biomarkers Prev; 1993; 2(4):363-7. PubMed ID: 8102291
[TBL] [Abstract][Full Text] [Related]
25. In colon carcinogenesis, the cytoskeletal protein gelsolin is down-regulated during the transition from adenoma to carcinoma.
Gay F; Estornes Y; Saurin JC; Joly-Pharaboz MO; Friederich E; Scoazec JY; Abello J
Hum Pathol; 2008 Oct; 39(10):1420-30. PubMed ID: 18656242
[TBL] [Abstract][Full Text] [Related]
26. Quantitative analysis of BRCA1, BRCA2 and Hmsh2 mRNA expression in colorectal Lieberkühnien adenocarcinomas and matched normal mucosa: relationship with cellular proliferation.
Le Corre L; Vissac-Sabatier C; Chalabi N; Bignon YJ; Daver A; Chassevent A; Bernard-Gallon DJ
Anticancer Res; 2005; 25(3B):2009-16. PubMed ID: 16158938
[TBL] [Abstract][Full Text] [Related]
27. Loss of MHC class II expression is associated with a decrease of tumor-infiltrating T cells and an increase of metastatic potential of colorectal cancer: immunohistological and histopathological analyses as compared with normal colonic mucosa and adenomas.
Warabi M; Kitagawa M; Hirokawa K
Pathol Res Pract; 2000; 196(12):807-15. PubMed ID: 11156321
[TBL] [Abstract][Full Text] [Related]
28. Comparative analysis of prognostic significance of molecular markers of apoptosis with clinical stage and tumor differentiation in patients with colorectal cancer: a single institute experience.
Ivanov K; Kolev N; Tonev A; Nikolova G; Krasnaliev I; Softova E; Tonchev A
Hepatogastroenterology; 2009; 56(89):94-8. PubMed ID: 19453036
[TBL] [Abstract][Full Text] [Related]
29. [Expression of phosphorylated protein kinase B and PTEN protein in ovarian epithelial cancer].
Qiao YH; Cheng J; Guo RX
Zhonghua Fu Chan Ke Za Zhi; 2007 May; 42(5):325-9. PubMed ID: 17673045
[TBL] [Abstract][Full Text] [Related]
30. Topoisomerase I protein expression in primary colorectal cancer and lymph node metastases.
Boonsong A; Curran S; McKay JA; Cassidy J; Murray GI; McLeod HL
Hum Pathol; 2002 Nov; 33(11):1114-9. PubMed ID: 12454816
[TBL] [Abstract][Full Text] [Related]
31. Multimarker phenotype predicts adverse survival in patients with lymph node-negative colorectal cancer.
Zlobec I; Minoo P; Baumhoer D; Baker K; Terracciano L; Jass JR; Lugli A
Cancer; 2008 Feb; 112(3):495-502. PubMed ID: 18076013
[TBL] [Abstract][Full Text] [Related]
32. Nuclear S100A4 is a novel prognostic marker in colorectal cancer.
Boye K; Nesland JM; Sandstad B; Mælandsmo GM; Flatmark K
Eur J Cancer; 2010 Nov; 46(16):2919-25. PubMed ID: 20719498
[TBL] [Abstract][Full Text] [Related]
33. Clinical impacts of mammalian target of rapamycin expression in human colorectal cancers.
Alqurashi N; Gopalan V; Smith RA; Lam AK
Hum Pathol; 2013 Oct; 44(10):2089-96. PubMed ID: 23773481
[TBL] [Abstract][Full Text] [Related]
34. KISS1 expression in colorectal cancer.
Kostakis ID; Agrogiannis G; Vaiopoulos AG; Mylona E; Patsouris E; Kouraklis G; Koutsilieris M
APMIS; 2013 Oct; 121(10):1004-10. PubMed ID: 24033850
[TBL] [Abstract][Full Text] [Related]
35. PTEN loss and KRAS activation leads to the formation of serrated adenomas and metastatic carcinoma in the mouse intestine.
Davies EJ; Marsh Durban V; Meniel V; Williams GT; Clarke AR
J Pathol; 2014 May; 233(1):27-38. PubMed ID: 24293351
[TBL] [Abstract][Full Text] [Related]
36. Loss of Dpc4 expression in colonic adenocarcinomas correlates with the presence of metastatic disease.
Maitra A; Molberg K; Albores-Saavedra J; Lindberg G
Am J Pathol; 2000 Oct; 157(4):1105-11. PubMed ID: 11021814
[TBL] [Abstract][Full Text] [Related]
37. In depth evaluation of the prognostic and predictive utility of PTEN immunohistochemistry in colorectal carcinomas: performance of three antibodies with emphasis on intracellular and intratumoral heterogeneity.
Ágoston EI; Micsik T; Ács B; Fekete K; Hahn O; Baranyai Z; Dede K; Bodoky G; Bursics A; Kulka J; Krenács T; Győrffy B; Harsányi L; Szász AM
Diagn Pathol; 2016 Jul; 11(1):61. PubMed ID: 27392434
[TBL] [Abstract][Full Text] [Related]
38. Clinicopathologic significance of minichromosome maintenance protein 2 and Tat-interacting protein 30 expression in benign and malignant lesions of the gallbladder.
Liu DC; Yang ZL
Hum Pathol; 2011 Nov; 42(11):1676-83. PubMed ID: 21543106
[TBL] [Abstract][Full Text] [Related]
39. [Expression of leptin and p-mTOR and their clinicopathological significance in human colon carcinoma].
Wang D; Chen J; Chen H; Duan Z; Xu Q; Wei M; Wang L; Zhong M
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2012 Mar; 37(3):233-7. PubMed ID: 22561505
[TBL] [Abstract][Full Text] [Related]
40. PTEN expression and mutation in colorectal carcinomas.
Li XH; Zheng HC; Takahashi H; Masuda S; Yang XH; Takano Y
Oncol Rep; 2009 Oct; 22(4):757-64. PubMed ID: 19724853
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
